IIT Delhi and Its Incubated Startup Reportedly Lie About FDA Approval, AIIMS Clinical Test

Last month on Women’s Day i.e 8th March, researchers at Indian Institute of Technology, Delhi (IIT Delhi) including a professor in the department of design — Prof Srinivasan Venkataraman and the institute’s incubated startup Sanfe, which was co-founded by 3rd year students of IIT Delhi, had launched Sanfe Period Pain Relief Roll On device to relieve periods pain and ease out the mood swings faced by women during menstruation cycle.

Developed by two B. Tech 3rd year students of IIT Delhi — Mr Archit Agarwal and Mr Harry Sehrawat, along with an a Professor Dr. Srinivasan Venkataraman at IIT Delhi, Sanfe Period Pain Relief Roll On is an essential oil based natural formulation which has to be applied during periods on cramp affected areas (lower abdominal area, lower back and legs).
According to AltNews investigative report, a fact checking and fake news busting website, Sanfe has made three claims on approvals by top medical and Clinical test agencies including Food and Drug Administration (FDA) of the U.S. . The startup, in its official website which is now deleted (see archived page), the startup had claimed — 1) it received ‘FDA approval claiming no side-effects’; 2) Received an ‘AYUSH ministry certificate of safety’ and 3) The product by the startup is developed, medically tested in collaboration with AIIMS Delhi.
Several top media outlets such as Indian Express, NDTV, Times of India, The Economic Times, India Today, DNA India, reported as per the Official IIT Delhi website’s press release.
However, in a surprise revelation, especially from a premier institute like IIT Delhi, a cross check email to all FDA, AIIMS and Aayush Ministry, it comes out that none of the claims are true and in case of FDA approval, the startup is in fact playing cheap word-game where it comfortably says that Sanfe doesn’t have the American FDA approval, but actually acquired the approval from FDA, Haryana.
As FDA approval of treatments is public information, cross check with two online databases here, (Drugs@FDA and Orange Book), it was found that Sanfe was not approved by the FDA.
Going forward, aAn email from AltNews team to Division of Drug Information in the FDA’s Center for Drug Evaluation and Research ([email protected]) also confirmed that ‘Sanfe Period Pain Relief Roll-On’ is NOT a U.S. FDA approved drug product (see screenshot of email response below).

Further when AltNews team confronted one of the co-founders, Archit Agarwal, about the reason behind the startup’s misleading claims on FDA approval, he said that the AYUSH certificate was ‘FDA like’ and hence was advertised that way.
Its very unfortunate that India’s premier institute like IIT Delhi, which counts Infosys co-founder N.R. Narayana Murthy, Flipkart founders Sachin Bansal, Binny Bansal and Nikesh Arora of Softbank as some of its notable alumni, fell short of code of ethics and tried to forge on medical claims that is related to health and women — two most lowest priorities of India, nowadays.

Follow Us On Facebook, Twitter & Instagram Please Share Your Stories, Press Release & Articles At [email protected]. To Read More News Daily, Subscribe To Our Push Notification at

See also  Startup Policy Rundown: Maharashtra, Jharkhand, J&K, Odisha, And Tamil Nadu To Upgrade Their Startup Policies, And More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker